Financement mené par les investisseurs existants Fountain Healthcare Partners et Panakès Partners ; Neuromod utilisera les fonds pour accélérer la commercialisation aux États-Unis et en Europe. DUBLIN, 11 mars 2025 /PRNewswire/ — Neuromod Devices Ltd. (Neuromod), une société irlandaise…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.